Trujillo Carlos 4
4 · PharmaCyte Biotech, Inc. · Filed Nov 22, 2023
Insider Transaction Report
Form 4
Trujillo Carlos
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2023-11-20+85,000→ 85,000 totalExercise: $2.18Exp: 2033-11-20→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The options vest 50% on November 20, 2023 and 50% on November 20, 2024.